WHO ICTRP trial
Study to investigate efficacy, safety and tolerability of Furamag in the…
EUCTR2019-002747-14-CZ · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-002747-14-CZ |
|---|---|
| Public title | Study to investigate efficacy, safety and tolerability of Furamag in the treatment of urinary tract infections |
| Scientific title | A multi-center, randomized, double-blind, double-dummy, parallel-group, active drug controlled, adaptive, Phase III study to investigate efficacy, safety and tolerability of Furamag (Furaginum solubile) in the treatment of microbiologically confirmed acute uncomplicated urinary tract infections. |
| Primary sponsor | "Olainfarm" AS |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Czechia;Czech Republic;Poland;Lithuania;Russian Federation;Latvia |
| Conditions | Microbiologically confirmed acute uncomplicated lower urinary tract infections in women. MedDRA version: 20.0 Level: HLT Classification code 10046577 Term: Urinary tract infections System Organ Class: 100000004862 ;Therapeutic area… |
| Interventions | Trade Name: Furamag Product Name: Furamag 50 mg hard capsules Pharmaceutical Form: Capsule, hard INN or Proposed INN: Furaginum solubile CAS Number: 21287-44-5 Other descriptive name: FURAGIN SOLUBLE Concentration unit: mg milligram(s)… |
| Registration date | Dec 4, 2021 |
| Target size | 745 |
| Secondary IDs | OF_FUM_CT1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: